Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LUCYW | US
0
0%
Healthcare
Medical Instruments & Supplies
30/06/2024
02/04/2026
0.07
0.07
0.07
0.07
Innovative Eyewear Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music take and make calls and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. The company sells its products through various e-commerce and retail distribution channels. Innovative Eyewear Inc. has a partnership with Lucyd. The company was founded in 2019 and is headquartered in North Miami Florida. Innovative Eyewear Inc. operates as a subsidiary of Lucyd Ltd.
View LessStrong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
100.7%1 month
114.8%3 months
182.5%6 months
290.8%-
-
-
-
-
-
-
-
-8.01M
-
-
-
-639.61
-
81.70
-96.53
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.04
Range1M
0.04
Range3M
0.08
Rel. volume
0.23
Price X volume
73.92
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| WORK Medical Technology Group LTD Ordinary Shares | WOK | Medical Devices | 1.15 | 0 | -2.54% | n/a | 0.00% |
| Cesca Therapeutics Inc | KOOL | Medical Devices | 13.0874 | 0 | 0.01% | n/a |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | 4.19 | - |
| Ent. to Revenue | - | 8.10 | - |
| PE Ratio | - | 47.18 | - |
| Price to Book | - | 5.71 | - |
| Dividend Yield | - | 1.35 | - |
| Std. Deviation (3M) | 182.52 | 56.96 | Riskier |
| Debt to Equity | - | 0.92 | - |
| Debt to Assets | - | 0.27 | - |
| Market Cap | - | 10.37B | - |